Delve Insight Market Research Reports





RSS Sort By :
TITLE Price Buy Now More options

DelveInsight “Polycystic kidney disease (PKD) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Polycystic kidney disease (PKD) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10...

$ 2750


DelveInsight’s Report, “Burns-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key...

$ 2000


DelveInsight’s Report, “Herpes Simplex Encephalitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers ac...

$ 2000


DelveInsight “Acute coronary syndrome (ACS) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Acute coronary syndrome (ACS) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 yea...

$ 2750


DelveInsight’s Report, “Cancer Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. ...

$ 2000


DelveInsight’s Report, “Herpes Simplex Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers acro...

$ 2000


DelveInsight Report, “Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2016” emphasizes on the currently active CAR-T cell products in research and development. The Report covers the 35...

$ 2450


DelveInsight “Venous thromboembolism (VTE) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Venous thromboembolism (VTE) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years...

$ 2750


DelveInsight’s Report, “Candidiasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. ...

$ 2000


DelveInsight’s Report, “Herpes Zoster (Shingles)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers acros...

$ 2000


DelveInsight “Bladder cancer - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Bladder cancer in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and...

$ 2750


DelveInsight’s Report, “Cellulitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. ...

$ 2000


DelveInsight’s Report, “Herpes Zoster Ophthalmicus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers acr...

$ 2000


DelveInsight “Myelofibrosis (MF) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Myelofibrosis (MF) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology histor...

$ 2750


DelveInsight’s Report, “Chancroid-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A...

$ 2000


DelveInsight’s Report, “Hormone Refractory Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacture...

$ 2000


DelveInsight “Autism spectrum disorder (ASD) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Autism spectrum disorder (ASD) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 y...

$ 2750


DelveInsight’s Report, “Chemotherapy Induced Nausea and Vomiting-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Man...

$ 2000


DelveInsight’s Report, “Hormone Replacement Therapy (HRT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufactur...

$ 2000


DelveInsight “Renal cell carcinoma - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Renal cell carcinoma in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology hi...

$ 2750


DelveInsight’s Report, “Chronic Bronchitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the ...

$ 2000

Live Chat Support
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest from Delve Insight. We have market research reports of all sectors covered by the Delve Insight; you can access and utilize them at economical budgets.

More about our Subscription option